MedTwenty
Companies

Paige

This profile is still being built. It is not yet listed in the company index.

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

Summary

Digital pathology company with FDA-cleared prostate cancer detection and an expanding European regulatory footprint.

Finances

Not published (small company accounts)

Timeline

No verified timeline entries yet.

MedTwenty coverage